Westchester Capital Management (New York)’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Westchester Capital Management (New York)’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-564,813	Closed	-$5.89M	–	406
2023 Q1	$5.89M	Buy	564,813 +229,812	+69%	+$2.38M	0.18%	153
2022 Q4	$3.44M	Hold	335,001	–	–	0.09%	233
2022 Q3	$3.37M	Buy	335,001 +135,101	+68%	+$1.35M	0.09%	214
2022 Q2	$1.99M	Hold	199,900	–	–	0.06%	235
2022 Q1	$1.99M	Buy	+199,900	New	+$1.98M	0.05%	232

Westchester Capital Management (New York)'s LVAC Position: Q2 2023 in Review

Westchester Capital Management (New York) sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 564,813 shares — an estimated $5.89M sold.

Westchester Capital Management (New York) first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $5.89M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Westchester Capital Management (New York) reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 564,813 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $5.89M.
Westchester Capital Management (New York) first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Westchester Capital Management (New York)'s LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $5.89M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2023, filed 14 Aug 2023.